
Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …
The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

